ÂÜÀòÂÒÂ×

Hubert Nowak is an experienced validation engineer currently serving as Validation Engineer III at Novo Nordisk since January 2023, and also engaged in validation engineering at Denison Pharmaceuticals since January 2022. Prior experience includes roles as a Validation QS Specialist at Wedgewood Pharmacy (2019 - 2022), and working in inpatient acute care pharmacy at Baystate Health (2001 - 2019). Previous positions also encompass outpatient long-term care pharmacy at Sunscript Pharmacy (2000 - 2002), and contributions to oncology biomarker research at the Maria Sklodowska-Curie National Research Institute of Oncology (1998 - 2000). Hubert's early career involved tablet and liquid syrup processing at Polfa S.A. (1997 - 2000). Academic achievements include a Master of Science in Pharmacy and a specialization in Drug Production Technology from the Medical University of Warsaw.